American Century Companies Inc Amgen Inc Transaction History

American Century Companies Inc

$160 Billion
Q2 2024

A detailed history of American Century Companies Inc transactions in Amgen Inc stock. As of the latest transaction made, American Century Companies Inc holds 312,542 shares of AMGN stock, worth $98.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

312,542

Previous 349,141 10.48%

Holding current value

$98.8 Million

Previous $99.3 Million 1.63%

% of portfolio

0.06%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $9.62 Million - $11.7 Million	-36,599 Reduced 10.48%	312,542 $97.7 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $651,740 - $786,733	-2,424 Reduced 0.69%	349,141 $99.3 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $89.9 Million - $101 Million	351,565 New	351,565 $101 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $512,952 - $636,845	2,346 Added 0.71%	335,086 $90.1 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $13.9 Million - $16.4 Million	-64,733 Reduced 16.29%	332,740 $73.9 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $13.6 Million - $16.6 Million	60,268 Added 17.87%	397,473 $96.1 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $9.54 Million - $12.1 Million	-41,671 Reduced 11.0%	337,205 $88.6 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $11.2 Million - $12.6 Million	49,828 Added 15.14%	378,876 $85.4 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $66.2 Million - $73.6 Million	-286,820 Reduced 46.57%	329,048 $80.1 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $10.2 Million - $11.3 Million	46,705 Added 8.21%	615,868 $149 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $6.8 Million - $7.78 Million	-34,187 Reduced 5.67%	569,163 $128 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $1.8 Million - $2.11 Million	8,477 Added 1.43%	603,350 $128 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $60.1 Million - $66.7 Million	-257,479 Reduced 30.21%	594,873 $145 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $75.6 Million - $88.1 Million	-340,502 Reduced 28.55%	852,352 $212 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.88 Million - $2.24 Million	-8,674 Reduced 0.72%	1,192,854 $274 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $10.5 Million - $11.7 Million	-44,655 Reduced 3.58%	1,201,528 $305 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $187 Million - $229 Million	943,323 Added 311.47%	1,246,183 $294 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $5.31 Million - $7.04 Million	-29,117 Reduced 8.77%	302,860 $61.4 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $40.8 Million - $52.4 Million	-215,477 Reduced 39.36%	331,977 $80 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $7.4 Million - $8.86 Million	42,490 Added 8.41%	547,454 $106 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $34.4 Million - $40.3 Million	-206,295 Reduced 29.0%	504,964 $93.1 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $11.9 Million - $13.5 Million	-66,058 Reduced 8.5%	711,259 $0
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $12.5 Million - $14.6 Million	-70,020 Reduced 8.26%	777,317 $151 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $1.51 Million - $1.7 Million	8,133 Added 0.97%	847,337 $176 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $125 Million - $140 Million	-750,418 Reduced 47.21%	839,204 $155 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $20 Million - $23.3 Million	-117,892 Reduced 6.9%	1,589,622 $271 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $72.5 Million - $81 Million	429,748 Added 33.63%	1,707,514 $297 Million
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $214 Million - $244 Million	1,277,766	1,277,766 $238 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Amgen Inc Transaction History